DEF 14C: Callan JMB Secures $25M Equity Line for Operations
Information Statement on Capital Raise
Callan JMB Inc. has secured an Equity Line of Credit for up to $25 million with Hexstone Capital LLC, approved by majority stockholders to fund operations and growth.
Summary
- Callan JMB Inc. entered into an Equity Line of Credit (ELOC) Purchase Agreement with Hexstone Capital LLC on July 24, 2025, for the potential sale and issuance of up to $25,000,000 in common stock.
- Majority stockholders, representing approximately 67.78% of voting power, approved the potential issuance of in excess of 19.99% of common stock (more than 895,765 shares) to Hexstone Capital LLC, as required by Nasdaq Rule 5635(d).
- The company has the right, but not the obligation, to sell shares to Hexstone over an 18-month period, commencing after a registration statement is declared effective by the SEC.
- The purchase price per share will be 95% (or 75% if not trading on Nasdaq Capital Market) of the lowest daily Volume Weighted Average Price (VWAP) over a specified measurement period.
- Hexstone is obligated to purchase between $500,000 and $2,000,000 of shares per 'Regular Purchase' as directed by the company, subject to certain conditions, including the common stock's closing price not being below $1.00.
- An exemption purchase notice for $550,000, representing 123,208 shares of common stock, was delivered to Hexstone on August 7, 2025.
- Proceeds from sales to Hexstone are expected to be used for operations, working capital, and other general corporate purposes.
- The company agreed to file a resale registration statement within 30 days of signing the ELOC Purchase Agreement and use commercially reasonable efforts to have it declared effective within 60 days (or 90 days if subject to full SEC review).
- Failure to meet registration statement deadlines will require the company to issue 25,000 shares of common stock to Hexstone.
- The company can terminate the ELOC Purchase Agreement at any time, but if less than $7.5 million in common stock has been sold, an additional commitment fee of $250,000 (cash or shares) is payable.
- Hexstone Capital LLC has agreed not to engage in short sales or hedging transactions that establish a net short position in the company's common stock during the term of the agreement.
- The actions approved by written consent will become effective on the 20th day after the Information Statement is mailed to stockholders, which is expected on or about October 3, 2025.
Sentiment
Score: 6
Explanation: The filing indicates a neutral to slightly positive sentiment. The company has secured access to significant capital, which is a positive for funding operations and growth. However, this comes with the potential for substantial shareholder dilution and sales at a discount, which are negative aspects. The agreement includes protective clauses like the prohibition on short selling by Hexstone, balancing some of the dilution concerns. Overall, it's a necessary financing step with inherent trade-offs.
Positives
- Secured access to up to $25,000,000 in capital through the Equity Line of Credit, providing funding for operations, working capital, and general corporate purposes.
- The company retains flexibility to control the timing and amount of common stock sales to Hexstone, allowing it to manage dilution and market impact.
- Hexstone Capital LLC is prohibited from engaging in short sales or hedging transactions that establish a net short position in the company's common stock, which could help mitigate downward pressure on the stock price.
- The ELOC provides a financing mechanism without the immediate need for a public offering, which can be beneficial in certain market conditions.
Negatives
- Potential for significant dilution for existing shareholders due to the issuance of common stock in excess of 19.99% of outstanding shares.
- Shares will be sold at a discount (95% or 75% of VWAP), which means the company receives less capital per share than the market price.
- The company faces a penalty of 25,000 shares of common stock if it fails to meet specified deadlines for filing and achieving effectiveness of the resale registration statement.
- A commitment fee of $250,000 is payable if the company terminates the ELOC Purchase Agreement before selling $7.5 million in common stock.
- Hexstone is not required to purchase shares if the closing price of the common stock is below $1.00, which could limit access to capital during periods of low stock performance.
Risks
- Significant dilution of existing shareholders' ownership and voting power due to the issuance of a substantial number of new common shares under the ELOC.
- The actual net proceeds from the ELOC are uncertain and depend on market conditions, the trading price of common stock, and the company's discretion in selling shares.
- Failure to timely file or obtain effectiveness for the resale registration statement could result in a penalty of 25,000 shares issued to Hexstone, further increasing dilution.
- The company's ability to raise capital through the ELOC is constrained if the common stock's closing price falls below $1.00, potentially limiting funding when most needed.
- The ELOC Purchase Agreement and Registration Rights Agreement contain customary representations, warranties, conditions, and indemnification obligations, which could expose the company to liabilities.
- Forward-looking statements in the filing are subject to numerous risks and uncertainties, and actual results may differ materially from expectations.
Future Outlook
The company expects to use any proceeds from the ELOC Purchase Agreement to support its operations, for working capital, and for other general corporate purposes. It does not anticipate paying cash dividends on its common stock in the foreseeable future. The company intends to purchase and maintain director and officer liability insurance when it becomes economically feasible.
Management Comments
- "We expect that any proceeds received by us from such sales to Hexstone will be used to support our operations, for working capital and for other general corporate purposes."
Industry Context
Equity lines of credit, such as the one Callan JMB Inc. has secured, are a common financing mechanism for smaller public companies, particularly those in early stages or with limited access to traditional capital markets. This type of financing provides a flexible, 'at-the-market' capital raising option, allowing companies to draw funds as needed, often at a discount to the prevailing market price. It is frequently used to fund ongoing operations, strategic initiatives, or bridge financing gaps, reflecting a broader trend among growth-oriented firms to leverage diverse funding sources.
Comparison to Industry Standards
- The ELOC structure, offering shares at a discount to VWAP (95% or 75%), is a standard feature in such agreements, reflecting the liquidity and commitment provided by the investor. This discount is comparable to similar financing arrangements seen with other small-cap companies seeking flexible capital.
- The 19.99% 'Exchange Cap' and the requirement for stockholder approval for issuances exceeding this threshold are directly in line with Nasdaq Listing Rule 5635(d), which aims to protect existing shareholders from excessive dilution without their consent. Many companies listed on Nasdaq Capital Market adhere to this rule when entering into equity financing agreements.
- The provision preventing Hexstone Capital LLC from engaging in short sales or hedging transactions is a protective measure often negotiated in ELOCs to align the investor's interests with the company's long-term stock performance, a practice observed in similar agreements across the industry.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Interim Chief Financial Officer | Jeffrey Appleman | Shannon Badger | May 14, 2025 | Appointment of interim CFO following the cessation of employment of the former CFO. |
| Former Chief Financial Officer | Jeffrey Appleman | May 13, 2025 | Cessation of employment with the company. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adoption | Adopted a written related-party transactions policy in October 2024, requiring the Audit Committee to review and approve/disapprove material related-party transactions. | October 2024 | Enhances oversight and transparency of transactions involving related parties, aiming to ensure they are on terms no less favorable than those with unaffiliated third parties and do not impair director independence. |
| Indemnification Provisions | Articles of incorporation and bylaws provide for indemnification of directors, officers, employees, and agents to the full extent permitted by Nevada Revised Statutes (NRS). | Upon completion of initial public offering (as per description of securities) | Offers broad protection to company personnel against liabilities incurred in their corporate capacities, potentially encouraging qualified individuals to serve, though the SEC views indemnification for Securities Act liabilities as unenforceable. |
Related Party Transactions
- Health Hero America (owned by Mr. Williams): The company's predecessor entity received a $110,736 advance in 2022, which was non-interest bearing and due on demand. This amount was fully repaid as of June 30, 2025, and December 31, 2024.
- Outlaw Run Ranch (ORR, owned by Mr. Williams): The company received rent receipts from a third-party vendor on behalf of ORR in 2023. The company also pays $9,800 per month to ORR for rent expenses. No amounts were owed to ORR as of June 30, 2025, and December 31, 2024.
- Warehouse Asset Management (majority owned by Messrs. Williams and Croyle): The company leases its headquarters, warehouse, other warehouse equipment, and a box truck for $15,425 per month. No amounts were owed to this entity as of June 30, 2025, and December 31, 2024.
- Advancements to a director: The company made advancements of $18,669 to a director in 2024. This amount was repaid in full in 2025.
- Stock options awarded to CEO's son: 100,000 stock options were awarded to the CEO's son as compensation for prior services, with 12,500 options vested and exercisable as of June 30, 2025.
- Reorganization with Coldchain Technology Services, LLC (CTS): On February 14, 2024, CTS exchanged 100% of its membership interest for 5,000,000 shares of common stock (3,750,000 to Wayne Williams and 1,250,000 to David J. Croyle). CTS is now a wholly-owned subsidiary.
- Stock reduction via Exchange and Reorganization Agreement: On November 14, 2024, Messrs. Williams and Croyle exchanged their existing shares for new shares at a 0.60:1 ratio, reducing total common stock outstanding from 5,000,000 to 3,000,000 shares.
Stakeholder Impact
- **Shareholders:** Face potential dilution from the issuance of new common stock under the ELOC, but benefit from the company's enhanced ability to fund operations and growth. Majority shareholders have already approved this action. No dissenters' rights are available.
- **Management and Employees:** Executive compensation details and employment agreements are outlined, providing clarity on their remuneration and incentives. The ELOC provides capital that can support the company's stability and growth, potentially benefiting employees through continued employment and opportunities.
- **Creditors:** The capital raise provides additional funding, which could improve the company's financial position and ability to meet its obligations, potentially reducing credit risk.
Next Steps
- Mail the Information Statement to stockholders on or about October 3, 2025.
- The actions approved by written consent will become effective on the 20th day after the Information Statement is mailed.
- File a resale registration statement with the SEC within 30 days of signing the ELOC Purchase Agreement.
- Use commercially reasonable efforts to have the resale registration statement declared effective by the SEC within 60 days (or 90 days if subject to full SEC review).
- The Compensation Committee and/or Board will annually review the base salaries for the CEO, EVP, and CMO.
- The Compensation Committee will set performance goals and payment matrices for executive incentive bonuses.
- The company intends to purchase and maintain director and officer liability insurance when it becomes economically feasible.
Key Dates
| Date | Description |
|---|---|
| 2022 | Company's predecessor entity received an advance of $110,736 from Health Hero America. |
| February 14, 2024 | Entered into a reorganization agreement and plan of share exchange with Coldchain Technology Services, LLC (CTS). |
| October 1, 2024 | Employment agreements with Eric Kash (EVP) and Dr. David Croyle (CMO) commenced. |
| October 15, 2024 | Employment agreement with Wayne Williams (CEO) became effective. |
| October 24, 2024 | Employment agreements for Wayne Williams, Eric Kash, and Dr. David Croyle were amended. |
| October 2024 | Board of directors adopted a written related-party transactions policy. |
| November 14, 2024 | Exchange and Reorganization Agreement among the company and existing stockholders to reduce common stock outstanding. |
| May 13, 2025 | Jeffrey Appleman ceased employment as Former Chief Financial Officer. |
| May 14, 2025 | Shannon Badger appointed Interim Chief Financial Officer. |
| July 24, 2025 | ELOC Purchase Agreement signed with Hexstone Capital LLC; Written Consent from Majority Holders received for stock issuance. |
| August 7, 2025 | Exemption purchase notice for $550,000 (123,208 shares) delivered to Hexstone. |
| September 23, 2025 | Date for beneficial ownership calculation. |
| October 3, 2025 | Expected mailing date of the Information Statement to stockholders. |
| 20th day after October 3, 2025 | Actions approved by written consent become effective. |
Recommendation
holdThe Equity Line of Credit provides Callan JMB Inc. with a flexible and significant source of capital, which is crucial for funding operations and strategic initiatives. This access to capital is a positive development, especially for a company that may have limited access to traditional financing. However, the potential for substantial dilution of existing shareholders' equity, coupled with the issuance of shares at a discount to market price, introduces considerable risk. The company's financial performance and operational specifics are not detailed in this information statement, making it difficult to assess the intrinsic value or immediate growth prospects. Given the balance between necessary capital infusion and potential dilution, a 'hold' recommendation is appropriate. Investors should monitor the company's utilization of the ELOC, its operational performance, and the impact of dilution on a per-share basis before making further investment decisions.
Keywords
Equity Line of Credit, ELOC, Hexstone Capital, Stockholder Approval, Common Stock Issuance, Dilution, Nasdaq Rule 5635(d), Capital Raise, SEC Filing, DEF 14C, Corporate Governance, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.